Profiling of Kidney Injury Biomarkers in Patients Receiving Cisplatin: Time-dependent Changes in the Absence of Clinical Nephrotoxicity.
about
Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving Cisplatin.Evaluating the Renal Safety of Investigational New Drugs: Where Should We Be Going?Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy.Therapeutic disasters that hastened safety testing of new drugs.Diagnostic accuracy of urinary biomarkers in infants younger than 3 months with urinary tract infection.Drugs and the Kidneys: Clinical Pharmacology Perspectives.
P2860
Profiling of Kidney Injury Biomarkers in Patients Receiving Cisplatin: Time-dependent Changes in the Absence of Clinical Nephrotoxicity.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Profiling of Kidney Injury Bio ...... ce of Clinical Nephrotoxicity.
@en
Profiling of Kidney Injury Bio ...... ce of Clinical Nephrotoxicity.
@nl
type
label
Profiling of Kidney Injury Bio ...... ce of Clinical Nephrotoxicity.
@en
Profiling of Kidney Injury Bio ...... ce of Clinical Nephrotoxicity.
@nl
prefLabel
Profiling of Kidney Injury Bio ...... ce of Clinical Nephrotoxicity.
@en
Profiling of Kidney Injury Bio ...... ce of Clinical Nephrotoxicity.
@nl
P2093
P2860
P356
P1476
Profiling of Kidney Injury Bio ...... nce of Clinical Nephrotoxicity
@en
P2093
Blessy George
Cindy O'Bryant
Daniel W Bowles
Madeleine Gomez
Melanie S Joy
Nickie Mercke
Susan L Hogan
P2860
P304
P356
10.1002/CPT.606
P407
P577
2017-02-14T00:00:00Z